학술논문
Daratumumab Improves Bone Turnover in Relapsed/Refractory Multiple Myeloma; Phase 2 Study “REBUILD”
Document Type
Article
Author
Source
In: Cancers . (Cancers, June-1 2022, 14(11))
Subject
Language
English
ISSN
20726694